These experiments showed that the Il10rb−/− CD103+ cDC1 vaccine suppressed bilateral tumor growth effectively, and to a similar degree as that observed upon vaccination with Stat3∆/∆ CD103+ cDC1s (Figure 5B,C). Here, IL10RB is linked to neoplasm.